The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m2 autologous hematopoietic stem cell transplantation

European Journal of Oncology Nursing

Volumn 15, Issue 5, 2011, Pages 508-512

  Vokurka, Samuel ^a   Bystricka, Eva ^a   Scudlova, Jana ^b   Mazur, Ewa ^c   Visokaiova, Maria ^d   Vasilieva, Elizabeth ^e   Brandejsova, Renata ^a   Chvojkova, Ivana ^a   Vrabcova, Martina ^a   Vitkova, Jitka ^b   Mjartanova, Dagmar ^b   Vodickova, Marcela ^b   Bockova, Jana ^d   Streinerova, Katerina ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^e PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Autologous transplantation; Cryotherapy; Oral mucositis; Risk factors; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CYTARABINE; ETOPOSIDE; MELPHALAN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CLINICAL TRIAL; CRYOTHERAPY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RISK FACTOR; STOMATITIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CRYOTHERAPY; CYTARABINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MELPHALAN; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STOMATITIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054752428     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2011.01.006     Document Type: Article

References (27)

1. Aisa Y., Mori T., Kudo M., et al. Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Supportive Care in Cancer 2005, 13:266-269.
2. Bensinger W., Schubert M., Ang K.K., et al. Task Force Report. Prevention and management of mucositis in cancer care. Journal of the National Comprehensive Cancer Network 2008, 6:1-21.
3. Blijlevens N., Schwenkglenks M., Bacon P., et al. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy-European Blood and Marrow Transplantation Mucositis Advisory Group. Journal of Clinical Oncology 2008, 26:1519-1525.
4. Branda R., Naud S., Brooks E., et al. Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy-induced mucositis and neutropenia. Cancer 2004, 100:1058-1064.
5. Cascinu S., Fedeli A., Fedeli S.L., Catalano C. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. European Journal of Cancer Part B: Oral Oncology 1994, 30:234-236.
6. Costa L.J., Micallef I.N., Inwards D.J., et al. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma. British Journal of Haematology 2008, 143:268-273.
7. Dodd M., Miaskowski C., Shiba G., et al. Risk factors for chemotherapy-induced oral mucositis: dental appliances, oral hygiene, previous oral lesions, and history of smoking. Cancer Investigation 1999, 17:278-284.
8. Grazziutti M.L., Dong L., Miceli M.H., et al. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplantation 2006, 38:501-506.
9. Keefe D.M., Schubert M.M., Elting L.S., Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007, 109:820-831.
10. Mahood D.J., Dose A.M., Loprinzi C.L., et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. Journal of Clinical Oncology 1991, 9:449-452.
11. McCarthy G., Awdej D., Ghandi H., et al. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncology 1998, 34:484-490.
12. Migliorati C.A., Oberle-Edwards L., Schubert M. The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis. Supportive Care in Cancer 2006, 14:533-540.
13. Montserrat V.L., Sonis S., Oster G. Burden of oral mucositis and/or esophagitis in patients undergoing radiation treatment for head and neck cancer or non-small cell lung cancer. Journal of Clinical Oncology 2004, 22:8104.
14. Niscola P., Romani C., Cupelli L., et al. Mucositis in patients with hematologic malignancies: an overview. Haematologica 2007, 92:222-231.
15. Overholser C. Oral care for cancer patients. Supportive Care 1996, 125-146. Marcel Dekker, N.York. J. Klastersky (Ed.).
16. Peterson D.E., Bensadoun R.J., Roila F. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Annals of Oncology 2009, 20:174-177.
17. Raber-Durlacher J. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Supportive Care in Cancer 2000, 8:366-371.
18. Raber-Durlacher J.E., Barasch A., Peterson D.E., et al. Oral complications and management considerations in patients treated with high-dose chemotherapy. Support Cancer Therapies 2004, 1:219-229.
19. Rapoport A., Miller Watelet L., Linder T., Eberly S., et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. Journal of Clinical Oncology 1999, 17:2446-2453.
20. Robien K., Schubert M., Bruemmer B., et al. Predictors of oral mucositis in patients receiving hematopoietic cell transplant for chronic myelogenous leukemia. Journal of Clinical Oncology 2004, 22:1268-1275.
21. Rubenstein E., Peterson D., Schubert M., et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004, 100:2026-2046.
22. Svanberg A., Ohrn K., Birgegard G. Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial. Journal of Clinical Nursing 2010, 19:2146-2151.
23. Sonis S. The pathobiology of mucositis. National Review of Cancer 2004, 4:277-284.
24. Sonis S., Elting L., Keefe D., et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004, 100:1995-2025.
25. Vokurka S., Bystricka E., Koza V., et al. Higher incidence of chemotherapy-induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Supportive Care in Cancer 2006, 14:974-976.
26. Vokurka S., Steinerova K., Karas M., et al. Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2. Bone Marrow Transplantation 2009, 44:601-605.
27. Worthington H.V., Glenny A.M., Mauleffinch L.F., et al. Using Cochrane reviews for oral diseases. Oral Diseases 2010, 16:592-596.